• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Report: Apple looks at iPhone for monitoring Parkinson’s patients

November 17, 2016 By Sarah Faulkner

Report: Apple looks at iPhone for monitoring Parkinson's patientsApple (NSDQ:AAPL) is reportedly conducting internal research into whether its iPhone and Apple Watch could be used to monitor drug dosage and wellness data for patients suffering from Parkinson’s disease. The company hopes to show the effectiveness of mobile monitoring, sources told Fast Company. 

Patients who suffer from Parkinson’s disease may only visit their doctor at 6-month intervals, which can lead to improper dosing if their condition improves or worsens. Apple’s efforts are led by Stephen Friend, according to the news outlet. Friend is a former member of Sage Bionetworks, a nonprofit that provides tools for biomedical research.

Other tech companies, like Samsung (KRX:005935), are also interested in understanding how mobile technology could be used to diagnose and monitor patients with Parkinson’s disease. Roche (PINK:RHHBY) is using a Samsung smartphone to collect data on participants in a Parkinson’s disease clinical trial between visits.

Neurologist Diana Blum told Fast Company that there are quantifiable metrics that healthcare professionals and researchers can track to better understand a patient’s condition.

“You could use mobile technology to monitor tremors and slowness—and maybe even stiffness and balance, but that’s more complicated,” Blum told the news outlet.

Some Parkinson’s patients do not have prominent tremors, which would make it difficult to track movement using a smartphone. But other patients, monitoring the severity of tremors and walking speed could be an important way to track their condition between visits to the doctor.

Filed Under: Featured, mHealth (Mobile Health), Patient Monitoring, Research & Development, Technology Tagged With: Apple, Roche, Samsung

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS